Nothing said here yet.
to join the conversation.
| DeSantis DamonDirector | Buy | 16,000 | $447.2K | Tue, Sep 15 |
| Kravitz HalDirector | Buy | 12,000 | $336.0K | Tue, Sep 15 |
| DeSantis DamonDirector | Buy | 20,000 | $553.0K | Mon, Sep 14 |
| Fieldly JohnChief Executive Officer | Buy | 18,000 | $493.8K | Thu, Sep 10 |
Celsius is on a mission to dominate the energy drink market, while Kimberly-Clark is a steady veteran, rewarding shareholders with a high-yielding dividend.
Celsius (CELH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
One is a growth stock but faces Pepsi dependency; the other is a more mature company but has massive operating cash flow.
Celsius Holdings has seen its share price fall sharply over the past year. That slide puts a spotlight on a simple question for you as an investor: Is the current valuation supported by the earnings power the business is generating today?
Investors are watching Celsius Holdings (CELH) ahead of its upcoming earnings release, after analysts flagged expectations for lower year-over-year profit even as full-year revenue estimates point to continued business expansion.
In the closing of the recent trading day, Celsius Holdings Inc. (CELH) stood at $28.31, denoting a -5.51% move from the preceding trading day.
CELH's international revenues are climbing as European expansion, strong Nordic demand and Alani Nu's planned overseas debut fuel long-term growth ambitions.
One generates triple-digit revenue growth with a lean balance sheet. The other is expanding aggressively but trades at a steep premium.
Celsius trades at half Dutch Bros' valuation despite triple the free cash flow, but Pepsi dependency poses a hidden risk.
Celsius Holdings, Inc. (NASDAQ:CELH) now controls three prominent energy-drink brands, but its valuation increasingly depends on something less visible than shelf space: how much of that portfolio’s growth reaches shareholders as earnings.
SJM vs. CELH: Which Stock Is the Better Value Option?